PFIZER INC Restructuring and Related Cost, Number of Positions Eliminated
PFIZER INC (PFE) reported Restructuring and Related Cost, Number of Positions Eliminated of 56.50 thousand Employee for the 108-month period ending 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2014-02-28
- 2013-12-31: Restructuring and Related Cost, Number of Positions Eliminated 108 month 56.50K Employee.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 108 month |
|---|---|
| 2013-12-31 | 56.50K Employee 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |